ATE403673T1 - Faktor-2 homolog zum fibroblasten-wachstumsfaktor und verfahren zu seiner anwendung - Google Patents

Faktor-2 homolog zum fibroblasten-wachstumsfaktor und verfahren zu seiner anwendung

Info

Publication number
ATE403673T1
ATE403673T1 AT96915686T AT96915686T ATE403673T1 AT E403673 T1 ATE403673 T1 AT E403673T1 AT 96915686 T AT96915686 T AT 96915686T AT 96915686 T AT96915686 T AT 96915686T AT E403673 T1 ATE403673 T1 AT E403673T1
Authority
AT
Austria
Prior art keywords
factor
fhf
growth factor
fibroblast growth
homologue
Prior art date
Application number
AT96915686T
Other languages
English (en)
Inventor
Jeremy Nathans
Philip Smallwood
Jennifer Macke
Original Assignee
Univ Johns Hopkins Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins Med filed Critical Univ Johns Hopkins Med
Application granted granted Critical
Publication of ATE403673T1 publication Critical patent/ATE403673T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT96915686T 1995-05-12 1996-05-10 Faktor-2 homolog zum fibroblasten-wachstumsfaktor und verfahren zu seiner anwendung ATE403673T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/438,439 US5876967A (en) 1995-05-12 1995-05-12 Fibroblast growth factor homologous factor-2 and methods of use

Publications (1)

Publication Number Publication Date
ATE403673T1 true ATE403673T1 (de) 2008-08-15

Family

ID=23740672

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96915686T ATE403673T1 (de) 1995-05-12 1996-05-10 Faktor-2 homolog zum fibroblasten-wachstumsfaktor und verfahren zu seiner anwendung

Country Status (9)

Country Link
US (3) US5876967A (de)
EP (1) EP0832109B1 (de)
JP (1) JP2001505526A (de)
AT (1) ATE403673T1 (de)
AU (1) AU708772B2 (de)
CA (1) CA2220917A1 (de)
DE (1) DE69637624D1 (de)
ES (1) ES2311290T3 (de)
WO (1) WO1996035716A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605441B1 (en) 1995-06-05 2003-08-12 Human Genome Sciences, Inc. Antibodies against fibroblast growth factor 11
US5763214A (en) * 1995-06-05 1998-06-09 Human Genome Sciences, Inc. Fibroblast growth factor 11
US6110893A (en) * 1995-06-05 2000-08-29 Human Genome Sciences, Inc. Fibroblast growth factor 11
US6020189A (en) 1996-08-30 2000-02-01 The Johns Hopkins University School Of Medicine Fibroblast growth factor homologous factors (FHFs) and methods of use
WO2010129784A2 (en) * 2009-05-06 2010-11-11 The Research Foundation Of The City University Of New York Isolated a-type fhf n-terminal domain peptides and methods of use
WO2025166217A1 (en) * 2024-01-31 2025-08-07 The Regents Of The University Of California Biomarker and therapeutic target for atrial fibrillation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763214A (en) * 1995-06-05 1998-06-09 Human Genome Sciences, Inc. Fibroblast growth factor 11
CA2217301A1 (en) * 1995-06-05 1996-12-12 Human Genome Sciences, Inc. Fibroblast growth factor 15
CA2249179A1 (en) * 1996-03-21 1997-09-25 The Johns Hopkins University School Of Medicine Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use

Also Published As

Publication number Publication date
EP0832109A1 (de) 1998-04-01
AU708772B2 (en) 1999-08-12
DE69637624D1 (de) 2008-09-18
JP2001505526A (ja) 2001-04-24
AU5739896A (en) 1996-11-29
US20030166875A1 (en) 2003-09-04
WO1996035716A1 (en) 1996-11-14
US20070066812A1 (en) 2007-03-22
US5876967A (en) 1999-03-02
EP0832109A4 (de) 2000-06-14
ES2311290T3 (es) 2009-02-01
CA2220917A1 (en) 1996-11-14
EP0832109B1 (de) 2008-08-06

Similar Documents

Publication Publication Date Title
DE69636720D1 (de) Dem fibroblasten wachstumsfaktor homologer faktor-1(fhf-1) und methoden zu seiner verwendung
DK0751992T3 (da) Karendotelvækstfaktor 2
DE69736976D1 (de) Mit Alzheimer Krankheit verknüpften Verfahren zur Diagnose, zur Herstellung von Medikamenten und zum Screenen von Substanzen sowie aus Beta-Amyloid abgeleiteten Peptiden
DE69840195D1 (de) Verfahren und zusammensetzungen zur behinderung der vervielfältigung von hiv-1
DE69735942D1 (de) Neuartige inhibitoren der aktivität des wachstumsfaktors für gefäss-endothelzellen (vegf), ihre verwendungen und verfahren zu ihrer herstellung
UA40621C2 (uk) Моноклональне антитіло, гібридомна клітинна лінія, поліпептид (варіанти), фрагмент днк (варіанти), фармацевтична композиція, спосіб одержання моноклонального антитіла
DE69129760D1 (de) T-cadherin-bindungsmolekül
HUT63652A (en) Process for producing cd44 surface protein variants, dna sequences encoding them and antibodies against them, as well as their application in diagnosis and therapy
SG43062A1 (en) Lymphocyte-associated cell surface protein
DE69634438D1 (de) Von humanem hitzeschockprotein 60 hergeleitete peptide zur behandlung von diabetis, entsprechende zusammensetzungen, verfahren und kits
CA2130900A1 (en) Therapeutic domains of von willebrand factor
ATE403673T1 (de) Faktor-2 homolog zum fibroblasten-wachstumsfaktor und verfahren zu seiner anwendung
ATE368110T1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
ATE71110T1 (de) Verfahren zur reinigung eines proteins.
WO1988003927A3 (en) Renin inhibitors
NO975565L (no) Benstimulerende faktor
DE3854420D1 (de) Onkogen kodierendes polypeptid, das wachstumsfaktoraktivität besitzt, verfahren zu seiner herstellung und verwendung.
ATE103816T1 (de) Impfstoff, geeignet zur verhuetung bzw. kontrolle der durch haemophilus pleuropneumoniae verursachte schweinekrankheit und verfahren zu dessen herstellung.
AU5327198A (en) Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
ATE449171T1 (de) Reagentia und verfahren zum nachweis von brustkrankheiten
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf
ATE60359T1 (de) Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung.
DE69736163D1 (de) Verfahren zur Expression von Polypeptide in Fishen durch wässerung in DNS enthaltende Lösung
ATE6639T1 (de) Ein gereinigtes polypeptid, ein verfahren zu dessen herstellung, dessen anwendung und das enthaltende pharmazeutische praeparat.
ATA261990A (de) Verfahren zur herstellung von n-(2-amino-3,5- dibrom-benzyl)-trans-4-aminocyclohexanol

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties